Ahmad Al-Mrabeh
Overview
Explore the profile of Ahmad Al-Mrabeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1835
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Taylor R, Al-Mrabeh A, Zhyzhneuskaya S, Peters C, Barnes A, Aribisala B, et al.
Cell Metab
. 2018 Oct;
28(4):667.
PMID: 30282047
No abstract available.
12.
Taylor R, Al-Mrabeh A, Zhyzhneuskaya S, Peters C, Barnes A, Aribisala B, et al.
Cell Metab
. 2018 Aug;
28(4):547-556.e3.
PMID: 30078554
The Diabetes Remission Clinical Trial reported return and persistence of non-diabetic blood glucose control in 46% of people with type 2 diabetes of up to 6 years duration. Detailed metabolic...
13.
Steven S, Hollingsworth K, Al-Mrabeh A, Avery L, Aribisala B, Caslake M, et al.
Diabetes Care
. 2018 Apr;
41(6):1321.
PMID: 29691229
No abstract available.
14.
Lean M, Leslie W, Barnes A, Brosnahan N, Thom G, McCombie L, et al.
Lancet
. 2017 Dec;
391(10120):541-551.
PMID: 29221645
Background: Type 2 diabetes is a chronic disorder that requires lifelong treatment. We aimed to assess whether intensive weight management within routine primary care would achieve remission of type 2...
15.
Taylor R, Leslie W, Barnes A, Brosnahan N, Thom G, McCombie L, et al.
Diabetologia
. 2017 Dec;
61(3):589-598.
PMID: 29188339
Aims/hypothesis: Substantial weight loss in type 2 diabetes can achieve a return to non-diabetic biochemical status, without the need for medication. The Diabetes Remission Clinical Trial (DiRECT), a cluster-randomised controlled...
16.
Al-Mrabeh A, Hollingsworth K, Steven S, Tiniakos D, Taylor R
PLoS One
. 2017 Apr;
12(4):e0174660.
PMID: 28369092
Objectives: Accumulation of intrapancreatic fat may be important in type 2 diabetes, but widely varying data have been reported. The standard quantification by MRI in vivo is time consuming and...
17.
Al-Mrabeh A, Hollingsworth K, Steven S, Taylor R
Diabetologia
. 2016 May;
59(8):1753-9.
PMID: 27179658
Aims/hypothesis: This study was designed to establish whether the low volume and irregular border of the pancreas in type 2 diabetes would be normalised after reversal of diabetes. Methods: A...
18.
Steven S, Hollingsworth K, Al-Mrabeh A, Avery L, Aribisala B, Caslake M, et al.
Diabetes Care
. 2016 Mar;
39(5):808-15.
PMID: 27002059
Objective: Type 2 diabetes mellitus (T2DM) is generally regarded as an irreversible chronic condition. Because a very low-calorie diet (VLCD) can bring about acute return to normal glucose control in...
19.
Steven S, Hollingsworth K, Small P, Woodcock S, Pucci A, Aribisala B, et al.
Diabetes Care
. 2015 Dec;
39(1):158-65.
PMID: 26628414
Objective: This study determined whether the decrease in pancreatic triacylglycerol during weight loss in type 2 diabetes mellitus (T2DM) is simply reflective of whole-body fat or specific to diabetes and...
20.
Hollingsworth K, Al-Mrabeh A, Steven S, Taylor R
Diabetologia
. 2015 Aug;
58(11):2676-8.
PMID: 26232098
No abstract available.